Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.
To examine metabolic changes (lipids, liver enzymes, blood pressure, and weight) potentially associated with conversion to diabetes, we analyzed serial glucose and other metabolic measures obtained every 6 months within the West of Scotland Coronary Prevention Study trial. Changes in parameters for 86 men who converted to new-onset diabetes ("converters": two consecutive glucose levels > or =7 mmol/l) were compared with 860 "nonconverters" matched for age and treatment allocation. Eighteen months before the diagnosis, converters to diabetes had elevated (P < 0.01) fasting glucose, weight, triglyceride, alanine aminotransferase (ALT), blood pressure, and white cell count and lower HDL cholesterol compared with nonconverters. The mean (SD) increase in fasting glucose over 18 months in converters was 1.80 (1.52) mmol/l, compared with 0.10 (0.57) in nonconverters. Of parameters measured, only ALT (P = 0.0005) and triglyceride (P = 0.030) increased significantly more over the 18 months in converters compared with nonconverters, but neither parameter increased significantly in nonconverters with high baseline glucose concentrations (>6.1 mmol/l). Finally, only sustained increases in ALT predicted a higher risk for diabetes. We conclude that a relatively rapid rise in fasting glucose levels is frequent in converters to diabetes and that associated increases over time in ALT and potentially triglyceride suggest hepatic fat accumulation as a contributing factor for conversion to diabetes in men at risk.
Sattar
Naveed
N
Department of Vascular Biochemistry, University of Glasgow, Glasgow, Scotland. nsattar@clinmed.gla.ac.uk
McConnachie
Alex
A
Ford
Ian
I
Gaw
Allan
A
Cleland
Stephen J
SJ
Forouhi
Nita G
NG
McFarlane
Peter
P
Shepherd
James
J
Cobbe
Stuart
S
Packard
Chris
C
D000273:Adipose Tissue / Q000033:anatomy & histology*; D000410:Alanine Transaminase / Q000097:blood*; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D003327:Coronary Disease / Q000150:complications* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology* / Q000378:metabolism; D006801:Humans; D015994:Incidence; D008055:Lipids / Q000097:blood; D008099:Liver / Q000033:anatomy & histology* / Q000201:enzymology; D008297:Male; D012606:Scotland / Q000453:epidemiology; D014280:Triglycerides / Q000097:blood*
D001786:Blood Glucose; D008055:Lipids; D014280:Triglycerides; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase